Robert D. Ciappenelli

Chief Commercial Officer, Dicerna Pharmaceuticals (United States).

Companies

Dicerna Pharmaceuticals (United States)Chief Commercial Officer Jun 7, 2019 to Dec 29, 2021¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Dicerna Pharmaceuticals (United States)0 shares²Dec 28, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 28, 2021U 14,813 shares at $38.25 of Dicerna Pharmaceuticals (United States)²
Dec 15, 2021Shares withheld for tax 1,241 shares at $38.05 of Dicerna Pharmaceuticals (United States)³
Dec 15, 2021Exercised options 3,425 shares of Dicerna Pharmaceuticals (United States)³
Dec 13, 2021Exercised options 8,856 shares at $22.58 of Dicerna Pharmaceuticals (United States)⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDicerna Pharmaceuticals (United States), Chief Commercial Officer
2
SEC EDGARDicerna Pharmaceuticals (United States) shares after the filing of Dec 28, 2021
3
SEC EDGARForm 4 filed Dec 17, 2021
4
SEC EDGARForm 4 filed Dec 14, 2021